Enovis Shares Outstanding 2010-2024 | ENOV
Enovis shares outstanding from 2010 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
| Enovis Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2023 | 54 |
| 2022 | 54 |
| 2021 | 51 |
| 2020 | 46 |
| 2019 | 46 |
| 2018 | 40 |
| 2017 | 41 |
| 2016 | 41 |
| 2015 | 42 |
| 2014 | 41 |
| 2013 | 33 |
| 2012 | 30 |
| 2011 | 15 |
| 2010 | 15 |
| 2009 | 14 |
| Enovis Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2024-09-30 | 56 |
| 2024-06-30 | 55 |
| 2024-03-31 | 55 |
| 2023-12-31 | 54 |
| 2023-09-30 | 55 |
| 2023-06-30 | 55 |
| 2023-03-31 | 54 |
| 2022-12-31 | 54 |
| 2022-09-30 | 54 |
| 2022-06-30 | 55 |
| 2022-03-31 | 54 |
| 2021-12-31 | 51 |
| 2021-09-30 | 53 |
| 2021-06-30 | 51 |
| 2021-03-31 | 47 |
| 2020-12-31 | 46 |
| 2020-09-30 | 46 |
| 2020-06-30 | 46 |
| 2020-03-31 | 47 |
| 2019-12-31 | 46 |
| 2019-09-30 | 46 |
| 2019-06-30 | 46 |
| 2019-03-31 | 45 |
| 2018-12-31 | 40 |
| 2018-09-30 | 39 |
| 2018-06-30 | 41 |
| 2018-03-31 | 41 |
| 2017-12-31 | 41 |
| 2017-09-30 | 41 |
| 2017-06-30 | 41 |
| 2017-03-31 | 41 |
| 2016-12-31 | 41 |
| 2016-09-30 | 41 |
| 2016-06-30 | 41 |
| 2016-03-31 | 41 |
| 2015-12-31 | 42 |
| 2015-09-30 | 42 |
| 2015-06-30 | 42 |
| 2015-03-31 | 42 |
| 2014-12-31 | 41 |
| 2014-09-30 | 42 |
| 2014-06-30 | 42 |
| 2014-03-31 | 38 |
| 2013-12-31 | 33 |
| 2013-09-30 | 38 |
| 2013-06-30 | 37 |
| 2013-03-31 | 32 |
| 2012-12-31 | 30 |
| 2012-09-30 | 32 |
| 2012-06-30 | 32 |
| 2012-03-31 | 27 |
| 2011-12-31 | 15 |
| 2011-09-30 | 15 |
| 2011-06-30 | 15 |
| 2011-03-31 | 15 |
| 2010-12-31 | 15 |
| 2010-09-30 | 15 |
| 2010-06-30 | 15 |
| 2010-03-31 | 14 |
| 2009-12-31 | 14 |
| 2009-09-30 | 14 |
| 2009-06-30 | 14 |
| 2009-03-31 | 14 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $2.475B | $1.707B |
| Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inspire Medical Systems (INSP) | United States | $5.669B | 176.81 |
| Hims & Hers Health (HIMS) | United States | $5.506B | 140.00 |
| Tempus AI (TEM) | United States | $5.393B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $2.799B | 0.00 |
| Privia Health (PRVA) | United States | $2.357B | 196.40 |
| Azenta (AZTA) | United States | $2.286B | 122.05 |
| Omnicell (OMCL) | United States | $2.053B | 67.15 |
| 10x Genomics (TXG) | United States | $1.718B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.568B | 0.00 |
| Schrodinger (SDGR) | United States | $1.486B | 0.00 |
| Phreesia (PHR) | United States | $1.464B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.846B | 0.00 |
| Standard BioTools (LAB) | United States | $0.651B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.563B | 0.00 |
| Talkspace (TALK) | United States | $0.529B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.476B | 82.40 |
| Health Catalyst (HCAT) | United States | $0.446B | 0.00 |
| TruBridge (TBRG) | United States | $0.297B | 86.52 |
| Pulmonx (LUNG) | United States | $0.257B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.209B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.114B | 0.00 |
| American Well (AMWL) | United States | $0.108B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.090B | 0.00 |
| HeartBeam (BEAT) | United States | $0.063B | 0.00 |
| CareCloud (CCLD) | United States | $0.062B | 0.00 |
| Outset Medical (OM) | United States | $0.061B | 0.00 |
| 111 (YI) | China | $0.054B | 0.00 |
| Zepp Health (ZEPP) | China | $0.043B | 0.00 |
| Zhongchao (ZCMD) | China | $0.043B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.041B | 0.00 |
| Movano (MOVE) | United States | $0.035B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.018B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.016B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.016B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.012B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.008B | 0.00 |
| Precipio (PRPO) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.005B | 0.00 |
| Syra Health (SYRA) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |